Related Experiment Video
Updated: Jun 23, 2025
05:21
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
25.2K
Pneumococcal and Influenza Vaccination Coverage in Patients with Heart Failure: A Systematic Review
Dimitrios Papagiannis1, Christos Kourek2, Alexandros Briasoulis3
1Public Health & Adults Immunization Lab, Department of Nursing, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece.
Journal of Clinical Medicine
|June 19, 2024
Summary
Heart failure patients need better pneumococcal and influenza vaccination coverage. This review found varied coverage rates but generally positive effects on survival and reduced hospitalizations for vaccinated individuals.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Heart failure patients are highly susceptible to respiratory infections.
- These infections can worsen cardiovascular conditions, leading to severe complications or death.
- Optimizing pneumococcal and influenza vaccination is crucial for this vulnerable group.
Purpose of the Study:
- To systematically review vaccination coverage for influenza and pneumococcus in heart failure patients between 2005 and 2023.
- To evaluate the impact of these vaccinations on survival and hospitalization rates.
Main Methods:
- Systematic review conducted following PRISMA guidelines.
- Searches performed in PubMed and Scopus databases.
- Analysis of 23 studies involving over 6 million participants.
Main Results:
- Influenza vaccination coverage varied widely (2.5%–97%).
- Pneumococcal vaccination coverage ranged from 20% to 84.6%.
- Most studies indicated that vaccination improved survival and reduced hospitalizations.
Conclusions:
- Significant variability exists in pneumococcal and influenza vaccination coverage among heart failure patients.
- Vaccination appears beneficial for improving outcomes in this population.
- Further efforts are needed to increase vaccination rates in heart failure patients.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
2.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K
01:30Pneumonia III: Complications and Assessment
198
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
198
01:28Pneumonia IV: Management
319
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
319
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:29Pneumonia II: Pathophysiology
253
The pathophysiology of pneumonia involves the following steps:
253